Diaminocyclopentane-derived <i>O</i>-GlcNAcase inhibitors for combating tau hyperphosphorylation in Alzheimer's disease

Patrick Weber, Zuzana Mészáros, Denis Jagečić, Valentina Hribljan, Dinko Mitrečić, Pavla Bojarová, Kristýna Slámová, Natalia Kulik, Arnold Stütz

Chemical Communications · 2022 · 11 citations · 22 references

Concepts

Abstract

We report the synthesis and testing of a novel type (new lead structure) of powerful and highly selective human O-N -acetyl-β- d -glucosaminidase (enzyme associated with Alzheimer's disease) inhibitors that are not based on transition state mimetics.

References

22